| The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity D Laoui, J Keirsse, Y Morias, E Van Overmeire, X Geeraerts, Y Elkrim, ... Nature communications 7 (1), 13720, 2016 | 258 | 2016 |
| The transcription factor STAT6 mediates direct repression of inflammatory enhancers and limits activation of alternatively polarized macrophages Z Czimmerer, B Daniel, A Horvath, D Rückerl, G Nagy, M Kiss, M Peloquin, ... Immunity 48 (1), 75-90. e6, 2018 | 214 | 2018 |
| The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology M Kiss, Z Czimmerer, L Nagy Journal of Allergy and Clinical Immunology 132 (2), 264-286, 2013 | 170 | 2013 |
| Myeloid cell heterogeneity in cancer: not a single cell alike M Kiss, S Van Gassen, K Movahedi, Y Saeys, D Laoui Cellular immunology 330, 188-201, 2018 | 138 | 2018 |
| Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy H Van Damme, B Dombrecht, M Kiss, H Roose, E Allen, E Van Overmeire, ... Journal for immunotherapy of cancer 9 (2), 2021 | 108 | 2021 |
| Systemic reprogramming of monocytes in cancer M Kiss, AA Caro, G Raes, D Laoui Frontiers in oncology 10, 1399, 2020 | 98 | 2020 |
| Lithocholic acid, a metabolite of the microbiome, increases oxidative stress in breast cancer P Kovács, T Csonka, T Kovács, Z Sári, G Ujlaki, A Sipos, Z Karányi, ... Cancers 11 (9), 1255, 2019 | 79 | 2019 |
| A neutrophil response linked to tumor control in immunotherapy J Gungabeesoon*, NA Gort-Freitas*, M Kiss*, E Bolli, M Messemaker, ... Cell 186 (7), 1448-1464. e20, 2023 | 77 | 2023 |
| CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers R Bill, P Wirapati, M Messemaker, W Roh, B Zitti, F Duval, M Kiss, JC Park, ... Science 381 (6657), 515-524, 2023 | 60 | 2023 |
| IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D M Kiss, L Vande Walle, PHV Saavedra, E Lebegge, H Van Damme, ... Cancer Immunology Research 9 (3), 309-323, 2021 | 51 | 2021 |
| The IL-4/STAT6 signaling axis establishes a conserved microRNA signature in human and mouse macrophages regulating cell survival via miR-342-3p Z Czimmerer*, T Varga*, M Kiss*, CO Vázquez, QM Doan-Xuan, ... Genome medicine 8, 1-22, 2016 | 46 | 2016 |
| Diamonds in the rough: harnessing tumor-associated myeloid cells for cancer therapy EJ Clappaert, A Murgaski, H Van Damme, M Kiss, D Laoui Frontiers in immunology 9, 2250, 2018 | 41 | 2018 |
| Beyond the M‐CSF receptor–novel therapeutic targets in tumor‐associated macrophages S Bonelli, X Geeraerts, E Bolli, J Keirsse, M Kiss, AR Pombo Antunes, ... The FEBS journal 285 (4), 777-787, 2018 | 38 | 2018 |
| A growth factor–expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15 A Patsalos, L Halasz, MA Medina-Serpas, WK Berger, B Daniel, ... Journal of Experimental Medicine 219 (1), e20210420, 2021 | 37 | 2021 |
| High salt inhibits tumor growth by enhancing anti-tumor immunity R Willebrand, I Hamad, L Van Zeebroeck, M Kiss, K Bruderek, A Geuzens, ... Frontiers in Immunology 10, 1141, 2019 | 37 | 2019 |
| Retinoid X receptor suppresses a metastasis-promoting transcriptional program in myeloid cells via a ligand-insensitive mechanism M Kiss, Z Czimmerer, G Nagy, P Bieniasz-Krzywiec, M Ehling, A Pap, ... Proceedings of the National Academy of Sciences 114 (40), 10725-10730, 2017 | 26 | 2017 |
| Innate immune defense mechanisms by myeloid cells that hamper cancer immunotherapy E Lebegge, SM Arnouk, PMR Bardet, M Kiss, G Raes, ... Frontiers in Immunology 11, 549487, 2020 | 16 | 2020 |
| Genomewide effects of peroxisome proliferator‐activated receptor gamma in macrophages and dendritic cells–revealing complexity through systems biology I Cuaranta‐Monroy, M Kiss, Z Simandi, L Nagy European journal of clinical investigation 45 (9), 964-975, 2015 | 13 | 2015 |
| Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages A Murgaski, M Kiss, H Van Damme, D Kancheva, I Vanmeerbeek, ... Cancer Research 82 (20), 3785-3801, 2022 | 12 | 2022 |
| Dynamic transcriptional control of macrophage miRNA signature via inflammation responsive enhancers revealed using a combination of next generation sequencing-based approaches Z Czimmerer, A Horvath, B Daniel, G Nagy, I Cuaranta-Monroy, M Kiss, ... Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1861 (1), 14-28, 2018 | 12 | 2018 |
Laszlo NagyProfessor and Co-Director, Johns Hopkins University School of Medicine and University of DebrecenEmail verificata su jhmi.edu
